ACIU— AC Immune SA

$2.83-3.41%

NasdaqMaterialsPharmaceutical Preparations

1 insider bought $31K worth of ACIU in the last 30 days — 6.9x above historical baseline·1 insider sold $28K in the last 30 days — 6.9x above baseline

Velocity Score — Last 17 Days

Buy Activity

Buy Velocity Score

6.93x

Buy Rate (90d)

111.11 sh/day

Buy Baseline Rate

—

Unique Buyers (90d)

Sell Activity

Sell Velocity Score

6.93x

Sell Rate (90d)

111.11 sh/day

Sell Baseline Rate

—

Unique Sellers (90d)

Price Chart

Loading…

Insider Transactions

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-05-15	2026-05-18	Pfeifer Andrea	Director & Chief Executive Officer	Sale	10.0K	$2.79	$28K	3.82M	View ↗
2026-04-15	2026-04-16	Pfeifer Andrea	Director & Chief Executive Officer	Purchase	10.0K	$3.14	$31K	3.83M	View ↗

Recent Congressional Transactions

No recent congressional transactions.

Financial Statements

Full financials →

No financial data available for ACIU.

Company may not file with SEC or CIK is unresolved.

Latest News

AC Immune Presents New Phase 1 Data Indicating Higher Uptake of TDP-43 PET Tracer ACI-19626 in Patients with ALS

Yahoo Finance7d ago

↗

AC Immune (ACIU) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Yahoo Finance15d ago

↗

Assertio accepts new buyout bid; AI biotech Isomorphic banks $2B

Yahoo Finance16d ago

↗

AC Immune CEO Andrea Pfeifer to retire after 23 years